What should hospitals do when patients demand unvaccinated donor blood?

• by Torie Bosch

• June 1, 2026

MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumors

Clinical study marks SurVaxM’s second phase 2 trial in a major cancer indication

• by

• May 7, 2026

• 4 min

Comprehensive safety analysis of the clinical spectrum of adverse events associated with immune checkpoint inhibitors based on FAERS

• by Caihong Qu, Xiaoying Wang

• May 1, 2026

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

• by Da Hyun Kim, Ho Joon Im, Won Kyoung Jhang, Sung Han Kang

• May 29, 2026